Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study

BACKGROUND: Mesenchymal stromal cells (MSC) may serve as an attractive therapy in renal transplantation due to their immunosuppressive and reparative properties. While most studies have used autologous MSCs, allogeneic MSCs offer the advantage of immediate availability for clinical use. This is of m...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Transl Med
Auteurs principaux: Reinders, Marlies E. J., Dreyer, Geertje J., Bank, Jonna R., Roelofs, Helene, Heidt, Sebastiaan, Roelen, Dave L., Zandvliet, Maarten L., Huurman, Volkert A. L., Fibbe, Wim E., van Kooten, Cees, Claas, Frans H. J., Rabelink, Ton J., de Fijter, Johan W.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2015
Sujets:
Protocol
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4632480/
https://ncbi.nlm.nih.gov/pubmed/26537851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-015-0700-0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires